Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients

Author： Chak W.L. Choi K.S. Wong K.M. Chan Y.H. Chau K.F. Li C.S.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.35, Iss.1, 2003-02, pp. : 280-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Cellcept Therapy in High-Risk Renal Transplant Recipients

By Isenberg A. Singh T.P. Shen G.K. Freed B.M. Conti D.J.

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1188-1189

Elsevier

Access to resources Recommend Favorite

Failure of Ganciclovir Prophylaxis of Primary Cytomegalovirus Disease in Immunologic High-Risk Recipients

By Conti D.J. Isenberg A. Shen G.K. Hahn A. Singh T.P.

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1314-1315

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients

By Abouna G.M. Al Arrayed A.S. Farid E. Awad C.K. Sharqawi S.A.-D. Tantawi M.

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4077-4078

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients

By Esmeraldo R.M. Donadi M.O.R.C. Oliveira M.L. Ponte C.N. Pinheiro P.M.A.

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3007-3008

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil in renal graft recipients with increased immune risk of graft loss

By Boratynska M. Magott M. Klinger M. Smolska D. Rychlewska B. Myszka K. Szepietowski T. Szyber P. Patrzalek D.

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 553-555

Elsevier

Access to resources Recommend Favorite